Immunization, measles second dose in Algeria
Algeria: Immunization, measles second dose was 90.0% in 2024. ▼ Falling
Immunization, measles second dose in Algeria, 1999–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
In 2024, immunization, measles second dose in Algeria stood at 90.0%.
The figure is down 3.2% on the previous year and down 9.1% over ten years.
Over the whole period, immunization, measles second dose in Algeria peaked at 99.0% in 2014 and was at its lowest, 71.0%, in 2022.
Algeria ranks 70th of 178 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Immunization, measles second dose in Algeria, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 1999 | 83.0% | — |
| 2000 | 78.0% | -6.0% |
| 2001 | 73.0% | -6.4% |
| 2002 | 93.0% | +27.4% |
| 2003 | 96.0% | +3.2% |
| 2004 | 94.0% | -2.1% |
| 2005 | 94.0% | +0.0% |
| 2006 | 98.0% | +4.3% |
| 2007 | 95.0% | -3.1% |
| 2008 | 96.0% | +1.1% |
| 2009 | 98.0% | +2.1% |
| 2010 | 95.0% | -3.1% |
| 2011 | 96.0% | +1.1% |
| 2012 | 95.0% | -1.0% |
| 2013 | 93.0% | -2.1% |
| 2014 | 99.0% | +6.5% |
| 2015 | 99.0% | +0.0% |
| 2016 | 96.0% | -3.0% |
| 2017 | 92.0% | -4.2% |
| 2018 | 77.0% | -16.3% |
| 2019 | 76.0% | -1.3% |
| 2020 | 74.0% | -2.6% |
| 2021 | 73.0% | -1.4% |
| 2022 | 71.0% | -2.7% |
| 2023 | 93.0% | +31.0% |
| 2024 | 90.0% | -3.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 83.0% | 83.0% | 83.0% | 1 |
| 2000s | 91.5% | 73.0% | 98.0% | 10 |
| 2010s | 91.8% | 76.0% | 99.0% | 10 |
| 2020s | 80.2% | 71.0% | 93.0% | 5 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0516 units per person (2025)
- Population ages 05-09, male, annual growth rate -0.5109 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0537 units per person (2025)
- Population ages 10-14, female, annual growth rate 3.37 % change on previous year (2025)
Frequently asked questions
- What is immunization, measles second dose in Algeria?
- Immunization, measles second dose in Algeria was 90.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Algeria?
- The highest recorded value was 99.0% in 2014.
- What is the lowest immunization, measles second dose recorded in Algeria?
- The lowest recorded value was 71.0% in 2022.
- How does Algeria rank for immunization, measles second dose?
- Algeria ranks 70th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Algeria?
- Over the last ten years it is down 9.1%. The long-run trend across the full record is falling.
- Where does this Algeria data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.